Biznesradar bez reklam? Sprawdź BR Plus
Notowania JNJ.US
151.01+1.77(+1.19%)(czas lokalny: 16.07.2024 16:00)Johnson & Johnson
WERSJA BETA
New York Stock Exchange Inc
Biznesradar bez reklam? Sprawdź BR Plus
Biznesradar bez reklam? Sprawdź BR Plus
Data: | |
---|---|
Kurs: | 151.01 |
Otwarcie: | 149.69 |
Min: | 149.16 |
Max: | 151.08 |
Wolumen: | 6 270 648 |
Min 52 tyg: | 143.13 |
Max 52 tyg: | 175.97 |
Zmiana | Zmiana % | Kurs odn. | Data odn. | |
---|---|---|---|---|
Zmiana 1d: | +1.77 | (+1.19%) | 149.24 | 15.07.2024 |
Zmiana 7d: | +5.53 | (+3.80%) | 145.48 | 08.07.2024 |
Zmiana 1m: | +5.47 | (+3.76%) | 145.54 | 14.06.2024 |
Zmiana 3m: | +3.42 | (+2.32%) | 147.59 | 15.04.2024 |
Zmiana YTD: | -5.73 | (-3.66%) | 156.74 | 29.12.2023 |
Zmiana 12m: | -8.86 | (-5.54%) | 159.87 | 14.07.2023 |
porównaj stopy zwrotu » |
WSKAŹNIKI AT
mocne kupuj
16 lip 22:00
mówią wskaźniki
RSI(14) | kupuj |
STS(14,3) | wykupiony |
MACD(12,26,9) | kupuj |
TRIX(14,9) | kupuj |
Williams %R(10) | wykupiony |
interwał dzienny
zobacz więcej wskaźników »
SYGNAŁY AT
Williams %R < -20
|
15 lip 22:00 |
FI > 0
|
9 lip 22:00 |
MACD > SIGNAL
|
9 lip 22:00 |
Williams %R > -80
|
9 lip 22:00 |
FI < 0
|
8 lip 22:00 |
SMA15 > SMA30
|
8 lip 22:00 |
MACD < SIGNAL
|
8 lip 22:00 |
interwał dzienny
zobacz więcej sygnałów »
TRENDY
3m | Trend boczny | |
6m | Trend boczny | |
12m | Trend boczny | |
24m | Trend spadkowy | |
36m | Trend spadkowy |
STOPY ZWROTU
stopa zwrotu | w stosunku do S&P 500 | |
---|---|---|
1m | +3.76% | -0.55% |
3m | +2.32% | -9.64% |
6m | -7.01% | -25.50% |
12m | -5.54% | -31.28% |
24m | -15.27% | -62.07% |
36m | -10.31% | -40.29% |
OSTATNIE WIADOMOŚCI
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2024 earnings results today. Reported sales increased 4.3% year-over-year to $22.4 billion. Operational sales growth was 6.6%. Net income decreased 12.8% to […]
The post Johnson & Johnson (JNJ) Q2 2024 Earnings: Key financials and quarterly highlights first appeared on AlphaStreet.
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) has constantly strengthened its portfolio over the years by acquiring new businesses, investing in new therapies, and expanding into new markets. The company’s […]
The post Johnson & Johnson to publish Q2 report next week. Here’s what to look for first appeared on AlphaStreet.
Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the consumer health business last year, the company has been focused […]
The post Key takeaways from Johnson & Johnson’s (JNJ) Q1 2024 earnings report first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion. The company reported net earnings of $5.3 billion, or $2.20 […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2024 financial results first appeared on AlphaStreet.
Johnson & Johnson (NYSE: JNJ) reported fourth quarter 2023 earnings results today. Reported sales increased 7.3% year-over-year to $21.4 billion. Net earnings increased 28% to $4.1 billion and EPS rose […]
The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q4 2023 financial results first appeared on AlphaStreet.
Dowiedz się więcej o wskaźnikach analizy technicznej i wykresach punktowo-symbolicznych.